Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06388382

Investigation of the Audible ICD Alert Tone

Ability of ICD patients to hear the audible ICD alert is being assessed.

Recruiting

Interested in participating?

Request Info

Key information

Age range

15 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital Cologne

Cologne, 50937, Germany

Location status: Recruiting

Location contact

Jakob Lüker, MD

CONTACT

[email protected]

+4922147832396

Jakob Lüker, MD

CONTACT

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patient equipped with a subcutaneous ICD
  • willing to participate

Exclusion criteria

  • S-ICD implantation within the past 3 weeks
  • patient is deaf

Treatment and study plan

Alert tone demonstration

Other

Patients are demonstrated the alert tone of their ICD

Primary outcomes

  1. Alert tone audible

    Time frame: 1 minute after demonstration

    Patients state if they hear or don't hear the alert tone

Study contacts

Contact information is provided by the study sponsor or research team.

Jakob Lueker

CONTACT

[email protected]

+4922147832396

Sponsors and collaborators

Lead sponsor

Universitätsklinikum Köln

Other

Registry information

Official study title

Investigation of the Audible Alert Tone in ICD Patients with Subcutaneous Cardioverter Defibrillators

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Apr 29, 2024
Registry last updated
Nov 8, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.